Idera Pharmaceuticals reported $37.73M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Aceto ACET:US 228.34M 7.92M
Agenus AGEN:US $ -228.84M 61.78M
Alnylam Pharmaceuticals ALNY:US $ 853.36M 72.83M
Amgen AMGN:US $ 8247M 1087M
Biogen BIIB:US $ 10751.9M 69.7M
Biomarin Pharmaceutical BMRN:US $ 4241.57M 79.56M
Cytrx CYTR:US 6.49M 1.1M
Dynavax Technologies DVAX:US $ 83.38M 16.38M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Gilead Sciences GILD:US $ 19710M 758M
GlaxoSmithKline GSK:LN 15377M 512M
Idera Pharmaceuticals IDRA:US $ 37.73M 4.58M
Mirati Therapeutics MRTX:US $ 1128.92M 130.49M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
Ultragenyx Pharmaceutical RARE:US $ 972.17M 82.41M